NCT05884775Terminated
Novel Digital Patient-Reported Outcomes Tool for Diabetes Management
iMatter2: An Artificial Intelligence (AI)-Driven Approach to Supercharge a Novel Digital Patient-reported Outcomes Tool for Diabetes Management
Source: ClinicalTrials.gov · Last updated 27 Aug 2026
Reason given: Funding was terminated for the study.
Brief summary (registry, in English)
Investigators will conduct a hybrid type 1 effectiveness-implementation randomized controlled trial (RCT) to evaluate the effectiveness of iMatter2 versus usual care on reduction in HbA1c at 12-months (primary outcome) among patients with Type 2 diabetes (T2D).
- Status (registry)
- Terminated
- Study type
- Interventional
- Enrollment
- 37 (actual)
- First submitted
- 23 May 2023
- Start date
- 4 Nov 2025
- Primary completion date
- 19 May 2026
- Lead sponsor
- NYU Langone Health
- Diseases
- Type 2 diabetes
- NCT number
- NCT05884775
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Have acute renal failure, end stage renal disease (ESRD) or evidence of dialysis, renal transplantation, or other ESRD-related services documented in the EHR;
- Have significant psychiatric comorbidity or reports of substance abuse (as documented in the EHR);
Other
- Patient Group:
- Refuse or are unable to provide informed consent;
- Are pregnant or planning to become pregnant within 12 months;
- Currently participate in another T2D study; or
- Plan to discontinue care at the clinic within the next 12 months.
Who the study is looking for
- PCP Group:
- Fulltime primary care provider (MD/DO, NP) practicing at the participating family health centers or faculty group practices and
- Provide care to at least five patients with a diagnosis of T2D
- Patient Group:
- Have a diagnosis of T2D for ≥6 months;
- Have uncontrolled T2D defined as HbA1c >7% documented in the EHR on at least two visits in the past year;
- Fluency in English or Spanish;
- Be willing to send/receive text messages; and
- Be > 18 years of age.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| NYU Langone Health | New York | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.